the firm's post-grant practitioners are some of the most experienced in the country.

Technologies

Artificial Intelligence (AI)
Artificial Intelligence (AI)
Digital Health
Digital Health
Energy & Renewables
Energy & Renewables

Fast Facts

About Our

Law Firm

About Our Law Firm

Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.

Get to know our

History

Get to know our History

1968
Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.

Our Local and

Global Reach

Our Local and Global Reach

Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.

A few of our

ACCOLADES

A few of our ACCOLADES

Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.

OPPORTUNITIES FOR YOUR

Career

OPPORTUNITIES FOR YOUR Career

From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.

A few ways to

GET In Touch

A few ways to GET In Touch
US Office

Telephone: 703-413-3000
Learn More +


Tokyo Office

Telephone: +81-3-6212-0550
Learn More +

Downloadable

Patent Forms

Downloadable Patent Forms

The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.

Stay informed with

Our Blogs

Board Reverses Examiner Rejections Because "Substantially" Is Descriptive Of A Known And Common Technique In The Art And The Examiner Failed To Establish A Factual Basis In Rendering An Obviousness Re

  • February 24, 2012
  • Blog Post

Associated People


In Ex parte Evans et al. (Appeal 2011-004119; Application serial no. 11/823,993), the Board reversed the Examiner’s rejection under 35 USC §112, second paragraph, and the 35 USC §103 rejection over the prior art.

The Examiner was of the view that the term “substantially” in the claimed method for cooling an internal combustion engine was indefinite because there was no standard in the specification. The relevant limitation at issue was “substantially filling the cooling system of the internal combustion engine with the heat transfer fluid such that the heat transfer fluid absorbs heat that is produced by the internal combustion engine and releases the absorbed heat to the atmosphere.” Appellants argued that the claim is definite because “one skilled in the art would readily understand what was meant by the use of the term.”

The Board agreed with the Appellants stating that “substantially filling” is used along with the functional recitation in the claim such that “any person skilled in the art, and indeed most laypersons, know, engine cooling systems may be considered ‘filled’ with slightly different levels in the cooling system. The terms ‘substantially filling’ are used in the claims as descriptive of this common technique and their use merely avoids a strict numerical level.”

The question answered in the obviousness rejection pertained to the heat transfer fluid and the specific weight ratio of propylene glycol relative to the combination of propylene and ethylene glycol. There was no dispute that these glycols were known in the heat transfer fluid art but the Examiner proffered no evidence that the relative weight ratio was known. Thus, the Board was left with an insufficient record and reversed the rejection because “evidence that merely shows the components are known, as in this case, is in our view insufficient to lead one of ordinary skill in the art to the particular combinations of components at particular proportions claimed.”